Illinois researchers develop new framework for nanoantenna light absorption

September 23, 2019

Harnessing light's energy into nanoscale volumes requires novel engineering approaches to overcome a fundamental barrier known as the "diffraction limit." However, University of Illinois researchers have breached this barrier by developing nanoantennas that pack the energy captured from light sources, such as LEDs, into particles with nanometer-scale diameters, making it possible to detect individual biomolecules, catalyze chemical reactions, and generate photons with desirable properties for quantum computing.

The results, which have a broad array of applications that may include better cancer diagnostic tools, were recently published in the Nano Letters, a prestigious peer-reviewed journal published by the American Chemical Society in a paper entitled "Microcavity-Mediated Spectrally Tunable Amplification of Absorption in Plasmonic Nanoantennas," The research was funded by the National Science Foundation.

To create a device capable of overcoming the diffraction limit, graduate student Qinglan Huang and her adviser, Holonyak Lab Director Brian T. Cunningham, a Donald Biggar Willett Professor in Engineering, coupled photonic crystals with a plasmonic nanoantenna, an innovative approach in the field. The photonic crystals serve as light receivers and focus the energy into an electromagnetic field that is hundreds of times greater than that received from the original light source, such as an LED or laser. The nanoantennas, when "tuned" to the same wavelength, absorb the energy from the electromagnetic field and concentrate the energy into a smaller volume that is yet another two orders of magnitude of greater intensity. The energy feedback between the photonic crystal and the nanoantenna, called "resonant hybrid coupling" can be observed by its effects on the reflected and transmitted light spectrum.

"To get cooperative coupling between two things is exciting because it's never been done," said Huang. "It's a general-purpose concept that we have experimentally demonstrated for the first time."

To achieve this, the team carefully controlled the density of the nanoantennas to maximize their energy collection efficiency. They also developed a method that allowed the nanoantennas to be distributed uniformly across the photonic crystal surface and tuned the photonic crystal's optical resonating wavelength to match the absorption wavelength of the nanoantennas.

In addition to changing how researchers can work with light, this new coupling method has the potential to change how and when cancer is diagnosed. One application is to use a gold nanoparticle, not much larger than biomolecules such as DNA, as the nanoantenna. In this case, the feedback provides a way to identify a biomarker unique to a certain type of cancer cell, and the group now linking the resonant hybrid coupling technique to novel biochemistry methods to detect cancer-specific RNA and DNA molecules with single-molecule precision. Cunningham, and other members of the Nanosensor Group will soon publish another paper that focuses specifically on the discovery's applications in regards to cancer diagnostics.

"Nano Letters is a very tough journal to get into," said Cunningham. "But the novel physics in this research and the potential for broad applications are what make this research stand out. The next steps of this research involve delving into the potential applications of this new process.

University of Illinois College of Engineering

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to